ELSE NUTRN HLDG BABYF
—
0.06
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow BABYF
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.09 | 0.11 | 0.06 | 0.05 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.26) | 0.75 | (0.43) | (0.50) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.21 | 0.24 | 0.35 | 0.38 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.21) | (1.04) | (0.65) | (0.75) | |
EV/FCF |
(0.21) | (1.10) | (0.66) | (0.76) | |
Quick Ratio |
0.20 | 0.20 | 0.12 | 0.19 | |
Current Ratio |
0.79 | 0.69 | 0.38 | 0.39 | |
Net Debt/EBITDA |
(0.61) | (1.53) | (0.62) | (2.89) | |
Debt/Assets |
18.38% | 21.03% | 59.51% | 62.42% | |
Debt/Equity |
(1.28) | (0.67) | (0.46) | (0.49) | |
Asset Turnover |
0.79 | 0.89 | 1.11 | 1.16 | |
Operating CF/Net income |
1.61 | (1.59) | 0.26 | 0.87 | |
Capex/Depreciation |
0.03 | 0.01 | (0.50) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | (0.30%) | 1.16% | |
Selling, General and Administrative Expense of Revenue |
77.34% | 58.90% | 182.42% | 67.05% | |
Intangible Assets out of Total Assets |
0.03 | 0.04 | 0.05 | 0.04 | |
Share Based Compensation of Revenue |
0.49% | 0.31% | (1.18%) | 0.07% | |
Graham Net Nets |
(1.92) | (2.49) | (11.57) | (18.18) | |
Graham Number |
4.08 | 4.54 | 9.12 | 7.21 | |
Earnings Yield |
(3,222.93%) | (2,458.14%) | (5,426.75%) | (8,603.50%) | |
Free Cash Flow Yield |
(1,128.95%) | (198.59%) | (820.72%) | (1,089.94%) | |
Revenue per Share |
0.36 | 0.32 | 0.17 | 0.24 | |
Operating CF per Share |
(0.55) | 0.19 | (0.19) | (0.08) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow per Share |
(0.55) | 0.19 | (0.19) | (0.08) | |
Cash per Share |
0.02 | 0.02 | 0.04 | 0.04 | |
Shareholders Equity per Share |
(0.16) | (0.27) | (0.85) | (0.67) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.16) | (0.27) | (0.85) | (0.67) | |
Free Cash Flow |
(1.67) | 0.70 | (0.66) | (0.35) | |
Working Capital |
(0.82) | (1.30) | (3.17) | (3.23) | |
Capital Expenditures |
0.00 | 0.00 | (0.02) | — | |
Net Current Asset Value |
(0.82) | (1.30) | (3.17) | (3.23) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.04 | 0.00 | |
Net Profit Margin |
(95.87%) | (36.18%) | (438.01%) | (37.91%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.25 | 1.04 | 0.72 | 0.89 | |
Average Payables |
1.45 | 1.15 | 1.74 | 1.69 | |
Average Inventory |
3.85 | 3.47 | 2.56 | 2.02 | |
Average Assets |
6.11 | 5.31 | 3.88 | 3.39 | |
Average Common Equity |
0.34 | 1.34 | (0.82) | (1.64) |
Columns are period end dates